Tue 1 Dec 2009 | 5:08 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For GTC Biotherapeutics, Inc.

GTC Biotherapeutics, Inc. (GTCB.O) (Consolidated Issue listed on NASDAQ Capital Market)
sector: Healthcare . industry: Biotechnology ยท View GTCB on other exchanges
As of  30 Nov 2009
0.92USD
Price Change
-0.08
Percent Change
-8.00%
 
Research Another Stock: Symbol Look-up

Name Total Annual Compensation Long-Term Incentive Plans All Other Fiscal Year Total
As Of 27 Dec 2008
Bechon, Christian -- -- -- --
Bullock, Francis -- -- -- --
Cox, Geoffrey 499,609 -- 81,320 690,909
Geraghty, James 170,000 -- -- 170,000
Green, John 314,466 -- 36,777 400,036
Heiden, William -- -- -- --
Landine, Michael -- -- -- --
McNamara, Pamela -- -- -- --
Meade, Harry 307,231 -- 37,258 392,953
Merot, Bertrand -- -- -- --
Nguyen, Evelyne -- -- -- --
Prost, Jean-Francois -- -- -- --
Scotland, Richard 254,139 -- 36,394 333,112
Tuck, Alan -- -- -- --
Woloshen, Daniel 267,307 -- 29,830 339,434